Cleveland Clinic Foundation Micrographic Surgery and Dermatologic Oncology

Topics

• Nonmelanoma Skin Cancer Studies 113
• Hair Growth and Disorders 99
• Mechanical Circulatory Support Devices 41
• Cutaneous Melanoma Detection and Management 38
• Transplantation: Methods and Outcomes 27
• Dermatology and Skin Diseases 24
• Skin Protection and Aging 24
• Psoriasis: Treatment and Pathogenesis 16
• Atrial Fibrillation Management and Outcomes 14
• Cancer and Skin Lesions 14
• Dermatologic Treatments and Research 14
• Reconstructive Facial Surgery Techniques 14

Most cited

1. Two Phase 3 Trials of Baricitinib for Alopecia Areata.

   The New England journal of medicine · 2022 · 395 citations · Natasha Mesinkovska

2. Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trial.

   Lancet (London, England) · 2023 · 223 citations · Natasha Mesinkovska

3. Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1).

   Journal of the American Academy of Dermatology · 2024 · 76 citations · Natasha Mesinkovska

4. The Alopecia Areata Severity and Morbidity Index (ASAMI) Study: Results From a Global Expert Consensus Exercise on Determinants of Alopecia Areata Severity.

   JAMA dermatology · 2024 · 31 citations · Natasha Mesinkovska

5. Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program.

   American journal of clinical dermatology · 2024 · 52 citations · Natasha Mesinkovska

6. Acral lentiginous melanoma. Part I. Epidemiology, etiology, clinical presentation, and diagnosis.

   Journal of the American Academy of Dermatology · 2026 · 16 citations ·